Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (81-90 of 322) with videos related to

Pageof 33
Sort By:
Cancer|January 11, 2016
Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorshipLori S Muffly, Fay J Hlubocky, Niloufer Khan, et al.
Journal of the National Cancer Institute|September 14, 2024
Health insurance continuity and mortality in children, adolescents, and young adults with blood cancerXu Ji, Xinyue Elyse Zhang, K Robin Yabroff, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2023
Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with ChemotherapyGuanghao Liang, Linchen Wang, Qiancheng You, et al.
Plos One|October 29, 2019
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencingVidya Balagopal, Andrew Hantel, Sabah Kadri, et al.
Bone Marrow Transplantation|January 14, 2018
Management of important adverse events associated with inotuzumab ozogamicin: expert panel reviewPartow Kebriaei, Corey Cutler, Marcos de Lima, et al.
Leukemia & Lymphoma|August 11, 2011
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panelWendy Stock, Dan Douer, Daniel J DeAngelo, et al.
The Cochrane Database of Systematic Reviews|October 10, 2020
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemiaCecilie U Rank, Line Stensig Lynggaard, Bodil Als-Nielsen, et al.
Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Pediatric Blood & Cancer|November 6, 2018
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)Matthew A Kutny, Susan Geyer, Kristina M Laumann, et al.
Journal of Adolescent and Young Adult Oncology|October 22, 2025
Feasibility of Symptom Burden Assessments and Early Palliative Care Integration in an Adolescent and Young Adult Leukemia ClinicSarah E Monick, Collin Hanson, K Sarah Hoehn, et al.
Pageof 33

Showing results (81-90 of 322) with videos related to

Sort By:
Pageof 33
Cancer|January 11, 2016
Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorshipLori S Muffly, Fay J Hlubocky, Niloufer Khan, et al.
Journal of the National Cancer Institute|September 14, 2024
Health insurance continuity and mortality in children, adolescents, and young adults with blood cancerXu Ji, Xinyue Elyse Zhang, K Robin Yabroff, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2023
Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with ChemotherapyGuanghao Liang, Linchen Wang, Qiancheng You, et al.
Plos One|October 29, 2019
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencingVidya Balagopal, Andrew Hantel, Sabah Kadri, et al.
Bone Marrow Transplantation|January 14, 2018
Management of important adverse events associated with inotuzumab ozogamicin: expert panel reviewPartow Kebriaei, Corey Cutler, Marcos de Lima, et al.
Leukemia & Lymphoma|August 11, 2011
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panelWendy Stock, Dan Douer, Daniel J DeAngelo, et al.
The Cochrane Database of Systematic Reviews|October 10, 2020
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemiaCecilie U Rank, Line Stensig Lynggaard, Bodil Als-Nielsen, et al.
Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Pediatric Blood & Cancer|November 6, 2018
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)Matthew A Kutny, Susan Geyer, Kristina M Laumann, et al.
Journal of Adolescent and Young Adult Oncology|October 22, 2025
Feasibility of Symptom Burden Assessments and Early Palliative Care Integration in an Adolescent and Young Adult Leukemia ClinicSarah E Monick, Collin Hanson, K Sarah Hoehn, et al.
Pageof 33